Overall, 28.8 million disability-adjusted life years due to dementia; 6.4 million attributed to modifiable risks.
Crude mortality rates for individuals with dementia were 5 times higher than for those without.
Adjustment for subclinical brain disease markers did not reduce link between arterial stiffness, dementia.
One in 2 women and 1 in 3 men will develop dementia, stroke, or parkinsonism during their lifetime.
Preeclampsia seems to be associated with an increased risk for dementia, especially vascular dementia, with a stronger correlation for late-onset disease.
A 7-item pain intensity measure for persons with dementia has shown initial validity and reliability.
Benefits seen were greater than for social interaction alone in older black population.
Repeated exposure to high levels of HbA1c was associated with increased risk for dementia in a cohort of patients age ≥50 with type 1 diabetes.
Increased dementia risk for those with abstinence or with drinking 14 units alcohol/week in midlife.
Findings for those with systolic BP 130 mm Hg at age 50 years
Administering a visual association test in patients with a small decline on the Mini-Mental State Examination during a 2-year period has substantial incremental value for identifying those at elevated risk for developing dementia.
Anticholinergic drugs for depression, urologic conditions, or Parkinson disease are associated with potential dementia occurrences up to 20 years after drug exposure.
Review of 4 studies shows positive link for clinically significant anxiety in midlife, future dementia
Alcohol use disorders are the strongest modifiable risk factors for onset of all types of dementia, especially early-onset dementia.
Apathy and depressive symptoms are independently associated with incident dementia in community-dwelling older people.
Higher BMI is associated with increased dementia risk when weight was measured more than 20 years before dementia diagnosis, but this association is reversed when BMI was assessed less than 10 years before dementia diagnosis.
Among women, but not men, mid-adulthood hypertension correlated with a 65% increased dementia risk.
Birth in a high stroke mortality state was associated with a significantly increased risk of dementia.
However, those who used PPIs were also more likely to use anticholinergic medicines that have been linked to cognitive difficulties.
Results from a 27-year follow-up study found no association between physical activity and a lower risk of dementia.
Regular proton pump inhibitor use in the elderly was associated with an increased risk of incident dementia compared with no proton pump inhibitor use, according to researchers.
The prevalence of dementia dropped about 24% between 2000 and 2012.
Facing dementia with strength and courage can inspire and comfort patients' families.
Both prescription and OTC proton pump inhibitors have been linked to an increased risk for development of dementia.
Patients administered low doses of benzodiazepines have an elevated risk of dementia and Alzheimer's disease compared with patients who received higher doses.
People who lose greater amounts of weight per decade later in life have an increased risk of mild cognitive impairment.
Older adults with dementia who took cholinesterase inhibitors had an increased risk of weight loss.
Diabetes patients who had a greater number of diabetes-related complications had an increased risk for dementia.
Research findings suggest the link between dementia risk and anticholinergic medications may persist and may not be reversible years after people stop taking these drugs.